Novel [tmco]
Diabetes [dsyn]
Drugs [phsu]
CARDIOVASCULAR [bdsy]
Specialist [prog]
Recently [tmco]
treatment [ftcn]
2 class [inpr]
Type 2 Diabetes [dsyn]
Drugs [phsu]
Events [evnt]
Patients [podg]
Diabetes [dsyn]
Cardiovascular disease [dsyn]
Group [idcn]
Cardiology clinic [inpr]
Sodium-Glucose Cotransporter 2 Inhibitor [phsu]
empagliflozin [carb, phsu]
Markedly [qlco]
Rapidly [qlco]
Reduced [qlco]
CARDIOVASCULAR [bdsy]
Heart failure [dsyn]
Hospitalization [hlca]
Likely [qlco]
Hemodynamic [ortf]
Metabolic [ftcn]
Drive [menp]
Mechanisms [ftcn]
Action [ftcn]
Recently [tmco]
Glucagon-like Peptide-1 Receptor Agonist [phsu]
liraglutide [aapp, horm, phsu]
Reduced [qlco]
CARDIOVASCULAR [bdsy]
adverse events [fndg]
CARDIOVASCULAR [bdsy]
SO [geoa]
Slowly [qlco]
Heart failure [dsyn]
Risks [qlco]
Suggest [idcn]
Alternative [cnce]
Mechanisms [ftcn]
Benefit [qnco]
Drug Therapy [topp]
Diabetes [dsyn]
Relative [famg]
CARDIOVASCULAR [bdsy]
findings [ftcn]
CARDIOVASCULAR [bdsy]
Benefit [qnco]
Trial [resa]
Mechanisms [ftcn]
Benefits [qnco]
Sodium-Glucose Cotransporter 2 Inhibitors [moft]
Glucagon-Like Peptide 1 [aapp]
agonists [phsu]
Suggest [idcn]
Drugs [phsu]
CARDIOVASCULAR [bdsy]
Specialists [prog]
cardiovascular events [fndg]
Mortality [qnco]
Patients [podg]
COLL [inpr]
American [popg]
College [mnob]
Cardiology [bmod]
Foundation [orgt]
